Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Aarkstore enterprise--- Womens Health: Diagnostic Testing

Posted Oct 27 2010 3:37am
Table of Contents :


1.0 Overview 7
1.1 Statement of Report 7
1.2 Scope of this Report 7
1.3 Methodology 8
1.4 Executive Summary 9

2.0 Introduction - Sector Overview 11
2.1 Global Diagnostic Products Industry 11

3.0 Womens Health Testing Market Analysis in Size, Growth and Share 13
3.1 Global Womens Health Testing Markets 13
3.1.1 Market Drivers in the Womens Health Diagnostics Testing Sector 13
3.1.1.1 Market Segments for Womens Health Testing 13
3.1.1.2 Key Players in the Womens Health Diagnostics Testing Segment 14
3.1.1.3 Womens Health Testing Sector Analysis 15
3.2 U.S. Womens Health Testing Market 15
3.2.1 Market Overview 15
3.2.2 Diagnostic Test Categories 16
3.3 European Womens Health Diagnostic Test Market 17
3.3.1 German Womens Care Diagnostic Market 20
3.3.2 U.K. Womens Care Testing Diagnostic Market 22
3.3.2.1 U.K. Market Statistics 23
3.3.2.2 U.K. Competitive Analysis 23
3.3.2.3 U.K. Market Access 25
3.3.3 French Womens Care Diagnostic Market 25
3.3.4 Italian Womens Care Diagnostic Market 25
3.3.5 Spanish Womens Care Diagnostic Market 26
3.4 Japanese Womens Care Testing Market 26
3.5 Chinese Womens Care Market 27
3.6 Rest of the World Womens Care Testing Market 29

4.0 Womens Health Testing Individual Markets 30
4.1 Pregnancy Testing 30
4.2 Osteoporosis Testing 36
4.2.1 In Vitro Blood Tests 40
4.2.2 Bone Densitometry Devices 42
4.3 Prenatal Screening Testing 43
4.3.1 Cystic Fibrosis 44
4.3.2 Prenatal Genetic Testing 47
4.3.3 Fragile X Syndrome 49
4.3.4 Tay-Sachs Disease 49
4.4 Fertility Testing 49
4.5 Breast Cancer 52
4.5.1 CA 15-3 53
4.5.2 CA 27-29 53
4.5.3 BRCA1 Breast and Ovarian Cancer Gene 53
4.5.4 BRCA2 Breast Cancer Gene 53
4.5.5 Tissue polypeptide antigen (TPA) 55
4.5.6 DNA Ploidy and S-phase Fraction 55
4.5.7 Estrogen and Progesterone Receptor (ER and PR) 55
4.5.8 HER-2 55
4.5.9 HER-2 and Herceptin 56
4.5.10 p53 56
4.5.11 NMP66 56
4.5.12 Mammastatin 57
4.6 Ovarian Cancer 57
4.6.1 CA 125 II™ 57
4.6.2 Steroid Hormone Receptors 59
4.6.3 Epidermal Growth Factor Receptor (EGFR) 59
4.6.4 HER-2/neu 59
4.6.5 P53 Tumor Suppressor Gene 59
4.6.6 Lysophospholipids 59
4.7 Cervical Cancer 60
4.7.1 Pap Smears 61
4.7.2 Human Papillomavirus (HPV) Testing 64
4.8 Miscellaneous Testing 68
4.8.1 Estriol 68
4.8.2 Fetal Fibronectin (fFN) 69
4.8.3 Vaginal pH and Vaginitis 69
4.9 Human Immunodeficiency Virus (HIV) 70
4.10 Infectious Disease Testing 72
4.10.1 Strep Testing 72
4.10.2 Chlamydia 75
4.10.3 Methicillin-Resistant Staphylococcus Aurea (MRSA) 76
4.10.4 Hepatitis 77
4.10.4 Gonorrhea 81
4.10.5 Urinary Tract Infections 81
4.11 Infant Jaundice 81

5.0 World Mammography Market 83
5.1 Mammography Overview 84
5.2 Market Overview 89
5.2.1 Introduction 89
5.2.2 World Mammography Markets Revenue 89
5.2.3 Mammography Markets by Region 90
5.2.4 Total Market Share 90
5.2.5 Competitive Structure 90
5.3 Market Opportunities 91
5.3.1 Resource Management for Mammography Markets 91
5.3.2 Movement to Higher Reimbursement Rates 91
5.3.3 Market Benchmarks for Increased Mammography Utilization 91
5.4 Market Analysis 92
5.4.1 Strategic Partnerships 92
5.4.2 Long Term Trends 92
5.5 Strategic Outlook 92
5.5.1 Competitive Elements of Mammography Markets 92
5.5.2 Higher Reimbursement Rates 92
5.5.3 Volume Requirements 93
5.5.4 Product Innovation 93
5.5.5 Product Leadership 93
5.5.6 Product Line Strategy 93
5.5.7 Pricing Strategy & Reimbursement 93
5.5.8 Strategic Partnerships 95
5.6 Film-Based Mammography Market 97
5.6.1 Market Overview 97


For more information please contact :

http://www.aarkstore.com/reports/Womens-Health-Diagnostic-Testing-1506.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
Post a comment
Write a comment:

Related Searches